Clinical Trial Update: Clinical Study of Multi-targeted CAR-T Therapy in Patients With Relapsed/Refractory B-Cell Lymphoma [Phase 1]

View source ↗

Summary

This entry provides an update on an ongoing Phase 1 clinical study of a multi-targeted CAR-T therapy for relapsed/refractory B-cell lymphoma, which is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma

Drugs mentioned

• Multi-targeted CAR-T Therapy

Snippet

Sponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | Conditions: B-cell Lymphoma | Phase 1 | Status: RECRUITING